| Shujuan Liu, MD | |
|
11109 Parkview Plaza Dr, Fort Wayne, IN 46845-1701 | |
| (260) 266-1000 | |
| (260) 422-0077 |
| Full Name | Shujuan Liu |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 31 Years |
| Location | 11109 Parkview Plaza Dr, Fort Wayne, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265870307 | NPI | - | NPPES |
| 300037181 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 01083525A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial University Medical Center | Savannah, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integrated Regional Laboratories Pathology Services, Llc | 9133244346 | 114 |
News Archive
Everist Genomics, a prognostics company focused on developing gene-based molecular assays for the prediction of cancer recurrence, today announced the positive results of the first external validation study of its OncoDefender-CRC colorectal cancer recurrence test. The study is being conducted by Mayo Validation Support Services, and is being coordinated with investigators and resources from all three Mayo Clinic sites.
Newborn screening performed in numerous states indicates that the incidence of the potentially life-threatening disorder, severe combined immunodeficiency, is higher than previously believed, at 1 in 58,000 births, although there is a high rate of survival, according to a study in the August 20 issue of JAMA.
Hospitals across the globe are becoming increasingly confident about their growth prospects for the year ahead despite rising costs and ongoing economic uncertainty, according to GE Capital's inaugural Hospital Sentiment Research – a report based on interviews with more than 380 senior hospital executives with responsibility for budget decisions over eight international markets.
Vedantra Pharmaceuticals, Inc., an immunotherapy company focused on developing products to treat cancer and infectious disease, and Neon Therapeutics, an immuno-oncology company developing neoantigen-based therapeutic vaccines and T-cell therapies to treat cancer, announced today that the companies have extended their non-exclusive research alliance.
› Verified 8 days ago
| Entity Name | Integrated Regional Laboratories Pathology Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942526298 PECOS PAC ID: 9133244346 Enrollment ID: O20170803001184 |
News Archive
Everist Genomics, a prognostics company focused on developing gene-based molecular assays for the prediction of cancer recurrence, today announced the positive results of the first external validation study of its OncoDefender-CRC colorectal cancer recurrence test. The study is being conducted by Mayo Validation Support Services, and is being coordinated with investigators and resources from all three Mayo Clinic sites.
Newborn screening performed in numerous states indicates that the incidence of the potentially life-threatening disorder, severe combined immunodeficiency, is higher than previously believed, at 1 in 58,000 births, although there is a high rate of survival, according to a study in the August 20 issue of JAMA.
Hospitals across the globe are becoming increasingly confident about their growth prospects for the year ahead despite rising costs and ongoing economic uncertainty, according to GE Capital's inaugural Hospital Sentiment Research – a report based on interviews with more than 380 senior hospital executives with responsibility for budget decisions over eight international markets.
Vedantra Pharmaceuticals, Inc., an immunotherapy company focused on developing products to treat cancer and infectious disease, and Neon Therapeutics, an immuno-oncology company developing neoantigen-based therapeutic vaccines and T-cell therapies to treat cancer, announced today that the companies have extended their non-exclusive research alliance.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shujuan Liu, MD 5700 Southwyck Blvd, Toledo, OH 43614-1509 Ph: (800) 288-8325 | Shujuan Liu, MD 11109 Parkview Plaza Dr, Fort Wayne, IN 46845-1701 Ph: (260) 266-1000 |
News Archive
Everist Genomics, a prognostics company focused on developing gene-based molecular assays for the prediction of cancer recurrence, today announced the positive results of the first external validation study of its OncoDefender-CRC colorectal cancer recurrence test. The study is being conducted by Mayo Validation Support Services, and is being coordinated with investigators and resources from all three Mayo Clinic sites.
Newborn screening performed in numerous states indicates that the incidence of the potentially life-threatening disorder, severe combined immunodeficiency, is higher than previously believed, at 1 in 58,000 births, although there is a high rate of survival, according to a study in the August 20 issue of JAMA.
Hospitals across the globe are becoming increasingly confident about their growth prospects for the year ahead despite rising costs and ongoing economic uncertainty, according to GE Capital's inaugural Hospital Sentiment Research – a report based on interviews with more than 380 senior hospital executives with responsibility for budget decisions over eight international markets.
Vedantra Pharmaceuticals, Inc., an immunotherapy company focused on developing products to treat cancer and infectious disease, and Neon Therapeutics, an immuno-oncology company developing neoantigen-based therapeutic vaccines and T-cell therapies to treat cancer, announced today that the companies have extended their non-exclusive research alliance.
› Verified 8 days ago
Dr. Vedran Uschuplich, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 2121 Lake Ave, Fort Wayne, IN 46805 Phone: 260-426-5431 | |
Dr. Sisira Ranasinghe, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 228d E Collins Rd, Fort Wayne, IN 46825 Phone: 260-471-7675 Fax: 260-471-0701 | |
Jeffrey P Squires, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 7950 W Jefferson Blvd, Fort Wayne, IN 46804 Phone: 260-435-7154 Fax: 260-435-7633 | |
Dr. Rohit Inder Singh, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 11109 Parkview Plaza Dr, Fort Wayne, IN 46845 Phone: 260-266-1000 | |
Dr. Sorensen Marie Sorensen, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 2121 Lake Ave, Va Nihcs Lab 113, Fort Wayne, IN 46805 Phone: 260-460-1422 | |
Dr. Keith Allen Henry, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 7950 W Jefferson Blvd, Fort Wayne, IN 46804 Phone: 260-435-2772 |